CTS Corp Reports Strong Q4 & Full-Year 2025 Results, Issues Positive 2026 Guidance
summarizeSummary
CTS Corp announced strong Q4 and full-year 2025 financial results, with significant growth in diversified markets and improved profitability, alongside positive sales and EPS guidance for 2026.
check_boxKey Events
-
Strong Q4 2025 Performance
Fourth quarter 2025 sales increased 9% year-over-year to $137 million, with diluted EPS rising to $0.67 from $0.38 in the prior year. Adjusted gross margin expanded by 150 basis points to 39.1%.
-
Solid Full-Year 2025 Results
Full-year 2025 sales grew 5% to $541 million, and diluted EPS reached $2.19, up from $1.80 in 2024. Adjusted gross margin improved by 150 basis points to 38.5%.
-
Diversified Markets Drive Growth
Sales to diversified end markets surged 16% for both Q4 and the full year 2025, now accounting for 57% of total revenue, offsetting a 7% decline in the transportation market for the full year.
-
Positive 2026 Guidance
The company projects full-year 2026 sales to be in the range of $550-$580 million and adjusted diluted EPS between $2.30-$2.45, indicating continued growth.
auto_awesomeAnalysis
CTS Corporation delivered robust financial performance for both the fourth quarter and full-year 2025, driven by significant growth in its diversified end markets. The company's strategic focus on diversification is yielding positive results, with these markets now representing 57% of total revenue. Despite a challenging transportation sector, overall sales and profitability metrics, including diluted EPS and adjusted margins, showed strong year-over-year improvements. The positive momentum is expected to continue into 2026, as indicated by the company's optimistic sales and adjusted EPS guidance. This filing provides a strong signal of operational execution and strategic success, particularly as the stock trades near its 52-week high.
At the time of this filing, CTS was trading at $55.58 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $34.02 to $56.15. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.